A Study to Investigate the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Decitabine and Tetrahydrouridine (NDec) When Administered Either as a Modified Release Formulation or an Immediate Release Formulation in Healthy Participants
Latest Information Update: 18 Dec 2024
At a glance
- Drugs Decitabine/tetrahydrouridine (Primary)
- Indications Sickle cell anaemia
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
Most Recent Events
- 16 Dec 2024 Status changed from recruiting to completed.
- 28 May 2024 Status changed from not yet recruiting to recruiting.
- 06 Mar 2024 New trial record